ReviewMolecular biology reports2025
Pain pathways and stem cells in endometriosis pathogenesis.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a gynecological disease, endometriosis is a disease in which pain and inflammation are important parts. Endometriosis is a chronic, estrogen-related situation with a multifactorial etiology that remains incompletely understood. Endometriosis affects approximately 6-10% of females and is a prominent reason of infertility. Despite being histologically benign, endometriosis displays invasive behaviors and is associated with systemic inflammatory responses and immune dysfunction. In this text, endometriosis pathogenesis and pain associated with endometriosis is comprehensively explored with particular emphasis on inflammation, pain mechanisms and the emerging role of stem cells. Several theories, including coelomic metaplasia, lymphovascular dissemination, retrograde menstruation, and embryonic rest theory have been recommended to clarify the ectopic location of endometrial tissue. Among these, the immune-mediated inflammatory microenvironment and aberrant neurogenesis are considered in disease progression and the development of pain. The multifactorial nature of endometriosis-associated pain-encompassing inflammatory, neuropathic, and oxidative stress-related mechanisms-highlights the limitations of hormonal treatments and the necessity for new therapeutic perspectives. In this respect, the involvement of stem cells, particularly endometrial and mesenchymal stem cells, has attracted growing interest. These cells are implicated not only in the pathophysiology of the disease but also show promise in regenerative and immunomodulatory therapies. This review aims to present an integrative perspective on endometriosis by examining recent evidence on inflammatory signaling, neuroimmune alterations, and stem cell biology. A deeper understanding of these mechanisms may open new avenues for personalized and multidisciplinary treatment strategies in endometriosis management.
Indexed as
Identifiers
40900210What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.